Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
It assumes the vial has been consistently stored at the correct temperature
Once absorbed, it binds to plasma proteins before it is transported around the body
That is roughly 3 vials per month
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Research teams can rely on the data generated with these compounds
US$ 28.61
US$ 25.33
US$ 28.38
US$ 22.36
US$ 28.54
US$ 23.65
US$ 24.60
US$ 29.80
US$ 25.52
US$ 24.58